Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McManis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurology|October 1, 1988
PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agentM D Muenter, J E Ahlskog, G Bell, et al.
Neurology|August 1, 1994
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysisL J Ptáĉek, R Tawil, R C Griggs, et al.
Annals of Neurology|March 1, 1993
Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysisL J Ptacek, L Gouw, H Kwieciński, et al.
Neurology|November 10, 2004
Correlating phenotype and genotype in the periodic paralysesT M Miller, M R Dias da Silva, H A Miller, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurology|October 1, 1988
PHNO [(+)-4-propyl-9-hydroxynaphthoxazine]: a new and effective anti-Parkinson's disease agentM D Muenter, J E Ahlskog, G Bell, et al.
Neurology|August 1, 1994
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysisL J Ptáĉek, R Tawil, R C Griggs, et al.
Annals of Neurology|March 1, 1993
Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysisL J Ptacek, L Gouw, H Kwieciński, et al.
Neurology|November 10, 2004
Correlating phenotype and genotype in the periodic paralysesT M Miller, M R Dias da Silva, H A Miller, et al.
Pageof 1